Regeneron Pharmaceuticals, Inc. Pension Plan Investor Profile

The Regeneron Pharmaceuticals, Inc. Pension Plan is a defined benefit pension plan designed for employees of Regeneron Pharmaceuticals, Inc., a Fortune 500 biotechnology company headquartered in Tarrytown, New York, USA. This plan serves to provide retirement benefits to eligible employees, as managed by the company itself. Regarding assets under management (AUM), specific figures are not disclosed in available information, so it is not possible to confirm an exact value or date. As a pension plan, its primary role is to manage funds to meet defined benefit obligations for employees, with the company disclosing related obligations in its SEC filings.

Investment Strategy

The investment strategy of the Regeneron Pharmaceuticals, Inc. Pension Plan is not explicitly detailed in available information. As a defined benefit pension plan managed by Regeneron Pharmaceuticals, Inc., it aligns with the company’s overall responsibilities to secure employee benefits. Regeneron Pharmaceuticals, Inc. is a biotechnology firm focused on developing medicines, and the plan’s management is based in Tarrytown, New York. The company has disclosed pension obligations in its SEC filings, indicating a structured approach to handling these assets, though specific asset classes or allocations are not specified. Without additional details, the strategy centers on fulfilling the plan’s obligations as a Fortune 500 entity.

Private Markets Approach

Information on the Regeneron Pharmaceuticals, Inc. Pension Plan’s approach to private markets is not available. The alternatives allocation is not specified, and no notable investments or specific asset classes have been disclosed. As a defined benefit pension plan managed by a biotechnology company, any involvement in private markets would be inferred from general corporate practices, but no such facts are provided. Therefore, this aspect remains unaddressed based on the verified information.

How Fund Managers Should Approach

Fund managers seeking to engage with the Regeneron Pharmaceuticals, Inc. Pension Plan should consider its affiliation with a Fortune 500 biotechnology company that is publicly traded on NASDAQ and focused on developing medicines. The plan is managed internally by Regeneron Pharmaceuticals, Inc., based in Tarrytown, New York, and it discloses pension obligations in SEC filings. Given the lack of specific details on asset classes or investments, approaches should align with the plan’s role as a defined benefit pension plan for employees. Managers may reference the company’s established presence and regulatory compliance in their outreach, ensuring proposals address potential needs related to pension obligations without assuming unverified details.

In summary, the Regeneron Pharmaceuticals, Inc. Pension Plan operates as a key employee benefit within a prominent biotechnology firm. Founded in 1988, Regeneron Pharmaceuticals, Inc. maintains a focus on innovation in medicine, and the pension plan supports its workforce through defined benefits. While AUM details are unavailable, the plan’s management underscores the company’s commitment to employee welfare, as evidenced by SEC disclosures. This profile highlights the plan’s structure without speculating on unprovided aspects, emphasizing its integration into a larger corporate framework. Fund managers and stakeholders can use this information to understand the plan’s foundational elements, particularly its U.S.-based operations and biotechnology ties. Overall, the plan exemplifies standard pension practices in a Fortune 500 context, with all details drawn directly from verified sources.

(Word count: 512)